Insulin Parenteral and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Insulin Parenteral and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Insulin (Parenteral)
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Parenteral-Lithium ER
- Insulin Parenteral-Lithium Oral Solution
- Insulin Parenteral-Lithium Salts
- Insulin Parenteral-Lithium Syrup and Oral Solution
- Insulin Parenteral-Lithobid
- Insulin Parenteral-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Insulin regular
- Lithium Controlled-Release and Extended-Release Tablets-Insulin Regular (U-100) Cartridges & Prefilled Syringes
- Lithium Controlled-Release and Extended-Release Tablets-Insulin Regular (U-100) Vials
- Lithium Controlled-Release and Extended-Release Tablets-Insulin Regular (U-500) Prefilled Pens
- Lithium Controlled-Release and Extended-Release Tablets-Insulin Regular (U-500) Vials
- Lithium Controlled-Release and Extended-Release Tablets-Insulin Regular IV Infusion